NEUROLOGY PROCEDURES
It is mandatory to present your medical prescription to be able to carry out the tests.
If you are a pregnant woman or if you suspect that you may be so, or if you are breast-feeding,
please notify it to our health staff before performing any test.
All nuclear medicine tests involve the administration of a radiopharmaceutical
with a very low dose of radioactivity, which is eliminated in the following hours through the urinary or digestive routes.
The access of companions to the center is allowed in the case of children and patients who require special attention.
The rest of the patients can come accompanied but, as a health precaution during the pandemic and depending on
the capacity of the waiting room and the criteria of our staff, it is possible that
the companion cannot wait inside the center.
NEUROLOGY PROCEDURES
It is mandatory to present your medical prescription to be able to carry out the tests.
If you are a pregnant woman or if you suspect that you may be so, or if you are breast-feeding,
please notify it to our health staff before performing any test.
All nuclear medicine tests involve the administration of a radiopharmaceutical
with a very low dose of radioactivity, which is eliminated in the following hours through the urinary or digestive routes.
The access of companions to the center is allowed in the case of children and patients who require special attention.
The rest of the patients can come accompanied but, as a health precaution during the pandemic and depending on
the capacity of the waiting room and the criteria of our staff, it is possible that
the companion cannot wait inside the center.
PERFUSION BRAIN TOMOGRAPHY (SPET)
POST-PHARMACOLOGICAL INTERVENTION
PERFUSION BRAIN TOMOGRAPHY (SPET)
POST-NEUROACTIVATION PERFUSION BRAIN TOMOGRAPHY (SPET)
DESCRIPTION: Evaluation of cerebral perfusion and brain metabolic activity through the administration of a perfusion/neuronal metabolism radiotracer.
PREPARATION: No special preparation is required. It is recommended to avoid the use of drugs acting on the central nervous system.
INDICATIONS: Evaluation of cerebral perfusion. Differential diagnosis of dementias (Alzheimer’s, Pick, multi-infarction). Pre-surgical evaluation of the epileptic patient: location of the epileptographic focus on complex partial crises and assessment of cerebral perfusion during the amobarbital test. Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder). Determination of cerebral vascular pathologies. Determination of Chronic Fatigue Syndrome. Evaluation of cranioencefacial traumatisms. Evaluation of clinical-radiological dissociation. Diagnosis of systemic diseases (LES, Behçet, etc.).
DURATION OF PROCEDURE: 40 minutes.
BRAIN ANGIOSCINTIGRAPHY
BRAIN SCINTIGRAPHY FOR ENCEPHALIC DEATH
DESCRIPTION: Evaluation of cerebral perfusion and brain metabolic activity through the administration of a perfusion/neuronal metabolism radiotracer.
PREPARATION: No special preparation is required. It is recommended to avoid the use of drugs acting on the central nervous system.
INDICATIONS: Evaluation of cerebral perfusion. Diagnosis of thromboembolic or infarct disease. Diagnosis of brain death.
TOMOGRAPHIC STUDIES: Differential diagnosis of dementias (Alzheimer’s, Pick, multi-infarction). Pre-surgical evaluation of the epileptic patient: location of the epileptographic focus on complex partial crises and assessment of cerebral perfusion during the amobarbital test. Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder). Determination of cerebral vascular pathologies. Determination of Chronic Fatigue Syndrome. Evaluation of cranioencefacial traumatisms. Evaluation of clinical-radiological dissociation. Diagnosis of systemic diseases (LES, Behçet, etc.).
DURATION OF PROCEDURE: 40 minutes.
DATSCAN BRAIN TOMOSCINTIGRAPHY
DOPAMINE (123I-IOFLUPANE) TRANSPORTERS BRAIN TOMOSCINTIGRAPHY (SPECT)
DESCRIPTION: Evaluation of the capture of ioflupane in the presynaptic dopaminergic receptors of the basal ganglia. Presynaptic study of the nigrostriatal way.
PREPARATION: No previous preparation required. Twenty drops of lugol (iodine solution) are administered 45-60 minutes before the procedure.
INDICATIONS: Differential diagnosis of Parkinson’s disease and Parkinsonian syndromes.
DURATION OF PROCEDURE: 4 hours.
abc
18F-FDG BRAIN PET-CT
DESCRIPTION: Study of the glucose metabolism of the brain.
PREPARATION: Four to six-hour fasting. The patients should take the usual medication. There is the possibility of withdrawing the psychotropic drugs. Diabetic patients should take their usual medication. If needed, a sedation will be performed 20 minutes after the administration of FDG, preferably before images acquisition, according to the anesthesia procedure.
INDICATIONS: Early and differential diagnosis of dementias. Study of movement disorders, for the characterization of atypical parkinsonisms. Delimitation of the epileptographic focus of interictal phase in epilepsy. Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder). Evaluation of cranioencephalic traumatisms and cerebrovascular pathologies.
DURATION OF PROCEDURE: 30 minutes.
PET-CT FOR THE DETECTION OF AMYLOID PLAQUE
DESCRIPTION: Evaluation of the presence of β-Amyloid in the brain.
PREPARATION: No previous preparation needed.
INDICATIONS: Early and differential diagnosis of dementias by determining the presence or absence of β-Amyloid.
DURATION OF PROCEDURE: 1 to 2 hours.
BRAIN PET-TC WITH 18F-DOPA
DESCRIPTION: Evaluation of Ioflupà uptake by dopaminergic receptors on the baseline lymphnodes. Pre-sinaptic study of nigrostriated way.
PREPARATION: No previous preparation is needed.
INDICATIONS: Differential diagnostic of Parkinson’s disease and parkinsonian syndroms.
DURATION OF PROCEDURE: 4 hours.
abc
Test per a l’avaluació de metàstasis i tumors cerebrals amb 18F-DOPA
DESCRIPCIÓ: Estudi de la captació dopaminèrgica en metàstasis i tumors cerebrals. Estudi de la diferenciació del alt i baix grau tumoral.
PREPARACIÓ: Dejú mínim de 4 hores abans de la prova.
INDICACIONS: Sospita de metàstasis, tumors cerebrals i recidiva cerebral.
DURADA DE LA PROVA: 1 hora.
BRAIN TOMOSCINTIGRAPHY (SPET/SPET-TC) WITH TUMORAL AFFINITY OR METABOLIC ACTIVITY RADIOTRACERS
DESCRIPTION: Evaluation of the encephalic uptake of thallium or technetium compounds by tumors.
PREPARATION: No previous preparation is necessary.
INDICATIONS: Evaluation of the degree of malignancy and metabolic activity of brain tumors. Evaluation of the therapeutic response of brain tumors to surgery or radiotherapy and detection of recurrences, allowing differentiation of radionecrosis. Differential diagnosis between lymphoma and other brain masses (toxoplasmosis …) in HIV-positive patients.
DURATION OF PROCEDURE: 2 to 24 hours.
CISTERNOGRAPHY
DESCRIPTION: Evaluation of the dynamics of the cerebrospinal fluid (CSF).
PREPARATION: No previous preparation is necessary. No fasting is required.
INDICATIONS: Diagnosis of normotensive hydrocephalus. Identification of liquorrheae or cerebrospinal fluid fistulae (CSF). Determination of the permeability of surgical derivations.
DURATION OF PROCEDURE: 48 hours.
CISTERNOGRAPHY
DESCRIPTION
Evaluation of the dynamics of the cerebrospinal fluid (CSF).
PREPARATION
-
No previous preparation is necessary.
-
No fasting is required.
INDICATIONS
- Diagnosis of normotensive hydrocephalus.
- Identification of liquorrheae or cerebrospinal fluid fistulae (CSF).
- Determination of the permeability of surgical derivations.
DURATION OF PROCEDURE
48 hours.
18F-FDG BRAIN PET-CT
DESCRIPTION
Study of the glucose metabolism of the brain.
PREPARATION
-
Four to six-hour fasting.
-
The patients should take the usual medication. There is the possibility of withdrawing the psychotropic drugs.
-
Diabetic patients should take their usual medication.
-
If needed, a sedation will be performed 20 minutes after the administration of FDG, preferably before images acquisition, according to the anesthesia procedure.
INDICATIONS
-
Early and differential diagnosis of dementias.
-
Study of movement disorders, for the characterization of atypical parkinsonisms.
-
Delimitation of the epileptographic focus of interictal phase in epilepsy.
-
Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder).
-
Evaluation of cranioencephalic traumatisms and cerebrovascular pathologies.
DURATION OF PROCEDURE
30 minutes.
BRAIN TOMOSCINTIGRAPHY (SPET/SPET-TC)
WITH TUMORAL AFFINITY OR METABOLIC
ACTIVITY RADIOTRACERS
DESCRIPTION
Evaluation of the encephalic uptake of thallium or technetium compounds by tumors.
PREPARATION
No previous preparation is necessary.
INDICATIONS
-
Evaluation of the degree of malignancy and metabolic activity of brain tumors.
-
Evaluation of the therapeutic response of brain tumors to surgery or radiotherapy and detection of recurrences, allowing differentiation of radionecrosis.
-
Differential diagnosis between lymphoma and other brain masses (toxoplasmosis …) in HIV-positive patients.
DURATION OF PROCEDURE
2 to 24 hours.
BRAIN ANGIOSCINTIGRAPHY
BRAIN SCINTIGRAPHY FOR ENCEPHALIC DEATH
PREFUSION BRAIN TOMOGRAPHY (SPET)
POST-PHARMACOLOGICAL INTERVENTION
PERFUSION BRAIN TOMOGRAPHY (SPET)
POST-NEUROACTIVATION PERFUSION
BRAIN TOMOGRAPHY (SPET)
DESCRIPTION
Evaluation of cerebral perfusion and brain metabolic activity through the administration of a perfusion/neuronal metabolism radiotracer.
PREPARATION
-
No special preparation is required.
-
It is recommended to avoid the use of drugs acting on the central nervous system.
INDICATIONS
-
Evaluation of cerebral perfusion.
-
Diagnosis of thromboembolic or infarct disease.
- Diagnosis of brain death.
TOMOGRAPHIC STUDIES:
- Differential diagnosis of dementias (Alzheimer’s, Pick, multi-infarction).
- Pre-surgical evaluation of the epileptic patient: location of the epileptographic focus on complex partial crises and assessment of cerebral perfusion during the amobarbital test.
- Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder).
- Determination of cerebral vascular pathologies.
- Determination of Chronic Fatigue Syndrome.
- Evaluation of cranioencefacial traumatisms.
- Evaluation of clinical-radiological dissociation.
- Diagnosis of systemic diseases (LES, Behçet, etc.).
DURATION OF PROCEDURE
40 minutes.
DATSCAN BRAIN TOMOSCINTIGRAPHY
DOPAMINE (123I-IOFLUPANE) TRANSPORTERS
BRAIN TOMOSCINTIGRAPHY (SPECT)
DESCRIPTION
-
Evaluation of the capture of ioflupane in the presynaptic dopaminergic receptors of the basal ganglia.
-
Presynaptic study of the nigrostriatal way.
PREPARATION
-
No previous preparation required.
-
Twenty drops of lugol (iodine solution) are administered 45-60 minutes before the procedure.
INDICATIONS
Differential diagnosis of Parkinson’s disease and Parkinsonian syndromes.
DURATION OF PROCEDURE
4 hours.
PET-CT FOR THE DETECTION
OF AMYLOID PLAQUE
DESCRIPTION
Evaluation of the presence of β-Amyloid in the brain.
PREPARATION
No previous preparation needed.
INDICATIONS
Early and differential diagnosis of dementias by determining the presence or absence of β-Amyloid.
DURATION OF PROCEDURE
1 to 2 hours.
PET-CT FOR THE PEDIATRIC EVALUATION OF
NEUROBLASTOMAS AND OTHER
NEUROENDOCRINE TUMORS WITH 18F-DOPA
DESCRIPTION
Study of dopaminergic uptake in neuroblastomas and other NET in children.
PREPARATION
Minimum 4-hour fasting before the procedure.
INDICATIONS
Evaluation of neuroblastomas and other neuroendocrine tumors.
DURATION OF PROCEDURE
1 hour.
ATRYS-SIMM IRLA
Josep Irla i Bosch Street, 5, Building 2
Barcelona 08034, Catalonia, SPAIN
Phone (+34) 93 204 6439
ATRYS-SIMM SJD
Santa Rosa Street 39, Pediatric Cancer Center Barcelona
Esplugues de Llobregat 08950, Catalonia, SPAIN
Phone (+34) 93 254 0470
FAX: (+34) 93 204 9641 · E-MAIL: info.simm@atryshealth.com
At ATRYS-SIMM your personal data is treated in accordance with the principles and rights contained in the GDPR law 2016/679 of April 27, 2016 and in the LOPDGDD law 3/2018 of December 5, 2018.
You can exercise your rights by contacting us by email to protecciondatos-sp@atryshealth.com.
ATRYS-SIMM IRLA
Josep Irla i Bosch Street, 5, Building 2
Barcelona 08034, Catalonia, SPAIN
Phone (+34) 93 204 6439
ATRYS-SIMM SJD
Santa Rosa Street, 39
Esplugues de Llobregat 08950, Catalonia, SPAIN
Phone (+34) 93 254 0470
FAX: (+34) 93 204 9641
E-MAIL: info.simm@atryshealth.com
At ATRYS-SIMM your personal data is treated in accordance with
the principles and rights contained in the GDPR law 2016/679 of
April 27, 2016 and in the LOPDGDD law 3/2018 of December 5, 2018.
You can exercise your rights by contacting us by
email to protecciondatos-sp@atryshealth.com.
